Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples